321 related articles for article (PubMed ID: 3274455)
1. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
[No Abstract] [Full Text] [Related]
2. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
Cole E; Robinson C; Bear R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
[No Abstract] [Full Text] [Related]
3. A comparison of three immunosuppressive protocols in patients aged over 50 years.
Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
[No Abstract] [Full Text] [Related]
4. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
5. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
Gaber AO; Thistlethwaite JR; Haag BW; Stuart J; Mayes J; Fellner S; Stuart FP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1915-6. PubMed ID: 3274451
[No Abstract] [Full Text] [Related]
6. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
7. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
[No Abstract] [Full Text] [Related]
8. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
[No Abstract] [Full Text] [Related]
9. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
10. Renal transplantation with cyclosporine in the elderly population.
Velez RL; Brinker KR; Vergne-Marini PJ; Nesser DA; Long DL; Trevino G; Dickerman RM; Helfrich GB
Transplant Proc; 1991 Apr; 23(2):1749-52. PubMed ID: 1905073
[No Abstract] [Full Text] [Related]
11. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
[No Abstract] [Full Text] [Related]
12. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
13. Renal transplantation in older patients on peritoneal dialysis.
Cardella CJ; Harding ME; Abraham G; Robinson C; Oreopoulos D; Uldall PR; Jordan M; Cook G; Struthers N; Honey R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2022-3. PubMed ID: 2652660
[No Abstract] [Full Text] [Related]
14. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
[No Abstract] [Full Text] [Related]
15. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
[No Abstract] [Full Text] [Related]
16. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
Sutherland DE; Fryd DS; Strand M; Ascher N; Simmons RL; Najarian JS
Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
[No Abstract] [Full Text] [Related]
17. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
Maddux MS; Veremis SA; Pollak R; Mozes MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
[TBL] [Abstract][Full Text] [Related]
18. Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
[No Abstract] [Full Text] [Related]
19. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
Rao KV; Andersen RC
Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
[No Abstract] [Full Text] [Related]
20. Management of immunosuppressive problems in renal allograft recipients.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
